SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-21-000034
Filing Date
2021-05-04
Accepted
2021-05-04 07:12:30
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cnce-20210331.htm   iXBRL 10-Q 1295953
2 EX-31.1 q12021exhibit311.htm EX-31.1 10655
3 EX-31.2 q12021exhibit312.htm EX-31.2 10621
4 EX-32.1 q12021exhibit321.htm EX-32.1 6153
5 EX-32.2 q12021exhibit322.htm EX-32.2 6078
  Complete submission text file 0001367920-21-000034.txt   5255173

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20210331.xsd EX-101.SCH 30090
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20210331_cal.xml EX-101.CAL 62909
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20210331_def.xml EX-101.DEF 135200
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20210331_lab.xml EX-101.LAB 456869
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20210331_pre.xml EX-101.PRE 284112
11 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20210331_htm.xml XML 797783
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 21885973
SIC: 2834 Pharmaceutical Preparations